GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | BCL2L11 | increases expression | EXP | | 6480464 | CTD | Dexamethasone results in increased expression of BCL2L11 mRNA | PMID:12782123 | BCL2L11 | increases phosphorylation | EXP | | 6480464 | CTD | Dexamethasone results in increased phosphorylation of BCL2L11 protein | PMID:20067466 | BCL2L11 | increases response to substance | EXP | | 6480464 | CTD | BCL2L11 protein results in increased susceptibility to Dexamethasone | PMID:14996839 | BCL2L11 | multiple interactions | EXP | | 6480464 | CTD | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of BCL2L11 mRNA; GSTM1 protein inhibits the reaction [Dexamethasone results in increased phosphorylation of BCL2L11 protein]; NR3C1 protein affects the reaction [Dexamethasone results in increased expression of BCL2L11 protein] | PMID:18515658 PMID:20067466 PMID:28628672 | BCL2L11 | increases expression | ISO | Bcl2l11 (Mus musculus) | 6480464 | CTD | Dexamethasone results in increased expression of BCL2L11 mRNA alternative form; Dexamethasone results in increased expression of BCL2L11 protein | PMID:14996839 PMID:17953376 | BCL2L11 | increases response to substance | ISO | Bcl2l11 (Mus musculus) | 6480464 | CTD | BCL2L11 protein results in increased susceptibility to Dexamethasone | PMID:14996839 | |
Go Back to source page | Continue to Ontology report |